Articles

The addition of goserelin to chemotherapy was shown to preserve ovarian function, fertility, and the ability to have a successful pregnancy in premenopausal women with hormone receptor–negative (HR–) early breast cancer, according to results of the Prevention of Early Menopause Study (POEMS), an international Intergroup trial coordinated by the Southwest Oncology Group. Read More ›

Two studies explored the beneficial effects of exercise and weight loss, one study in healthy women and another in breast cancer survivors. Read More ›

Pegfilgrastim, which mobilizes white blood cells that fight infection, is indicated by the US Food and Drug Administration for the treatment of cancer patients with nonmyeloid malignancies who are receiving anticancer drugs that are associated with clinically significant febrile neutropenia. Read More ›

National Breast Cancer Awareness Month (NBCAM) originated in October 1985 when the American Cancer Society (ACS) partnered with the pharmaceutical division of Imperial Chemical Industries, now part of AstraZeneca, to sponsor a weeklong event. Read More ›

Cancer and its treatments affect sexuality, but this is not typically discussed with patients. Patients with cancer are often not forthcoming about sexuality, and nurses and other healthcare practitioners may not be comfortable raising the issue. Read More ›

aginal dehydroepiandrosterone (DHEA) may improve sexual function, without negative systemic effects, in women with breast and gynecologic cancer with vaginal and sexual-related complaints. Read More ›

Imagine you’ve been feeling more tired lately, but you think, who isn’t? You work long hours at the office and at home. The fatigue becomes worse. After a battery of blood tests, the practitioner tells you the results. Read More ›

In breast cancer patients with bone metastasis, less frequent infusion of zoledronic acid was as effective as the standard monthly dose, the randomized OPTIMIZE-2 study showed. Read More ›

Recently, the American College of Physicians (ACP) released a statement on its website with the headline “American College of Physicians recommends against screening pelvic examination in adult, asymptomatic, average risk, non-pregnant women.” Read More ›